Shimadzu U.S.A Manufacturing, Inc. (SUM) (Oregon, USA – President: Shinichi Matsunaga), the U.S. manufacturing subsidiary of Shimadzu Corporation (Kyoto, Japan – President: Akira Nakamoto), has obtained ISO 13485 certification for the manufacture of high-performance liquid chromatographs (LC) and high-performance liquid chromatograph mass spectrometers (LCMS). ISO 13485 is the globally recognized international quality management standard for […]
AUSTIN, Texas — Luminex Corporation (NASDAQ: LMNX) today announced it has received U.S. FDA and European clearance for a comprehensive genotyping assay, xTAG® CYP2C19 Kit. This new test enables a personalized approach to aid physicians in determining patient treatment plans based on certain genetic variants of the P450 2C19 gene. “Since cytochrome [CYP450] enzymes are […]
SAN DIEGO — Illumina (NASDAQ:ILMN) today announced it has appointed Dr. Richard Klausner as Senior Vice President and Chief Medical Officer. Dr. Klausner will report to President and Chief Executive Officer Jay Flatley and will lead Illumina’s strategies for advancing genomics into clinical medicine and public health. He will also become part of Illumina’s executive […]
SAN DIEGO — Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced that its Board of Directors has authorized a review of potential strategic alternatives for its Genetic Analysis business segment. The review will include evaluation of a full range of potential strategic alternatives for the […]
MILFORD, Mass. — SeraCare Life Sciences, a manufacturer of life sciences tools, bulk plasma, and quality controls for diagnostic companies and clinical laboratories, announced an expansion of its research and manufacturing facilities at its Milford, Massachusetts headquarters. The addition of the state-of-the-art facility was driven by new companion diagnostic manufacturing opportunities with key diagnostic partners […]
Franklin Lakes, NJ – BD (Becton, Dickinson and Company) (NYSE: BDX) announced today that a jury has returned a mixed verdict in the lawsuit filed against the Company by Retractable Technologies, Inc. (RTI) in the United States Court for the Eastern District of Texas. The verdict was unfavorable to BD with respect to RTI’s Lanham […]
GLASGOW, Scotland — Life Technologies Corporation (NASDAQ: LIFE) today announced the opening of its first Customer Experience Centre in Russia in partnership with Khimexpert, an authorized distributor of the company, providing customers with access to the latest cutting-edge technology. Located in Moscow, the center is equipped with the most advanced genetic analysis systems and qualified […]
NEW YORK, Sept. 19, 2013 /PRNewswire/ — Exosome Diagnostics today announced it has entered into a collaboration agreement with Eli Lilly and Company (NYSE: LLY) for biomarker discovery and validation using Exosome Diagnostics proprietary EXO50 nucleic acid extraction kit. Under the agreement, Lilly will gain early access to Exosome Diagnostics technology to help identify key […]
REDWOOD CITY, Calif. — Illumina, Inc. (NASDAQ: ILMN) today announced Verinata Health, an Illumina company, published additional peer-reviewed data1 showing that Verinata’s non-invasive verifi® prenatal test2 correctly detects aneuploidies across all test samples, even for patients with very low fetal fractions (cell-free DNA fragments in maternal blood contributed from the fetus). The publication also documented […]
SANTA CLARA, Calif. — Agilent Technologies Inc. (NYSE: A) today announced it has combined its Life Sciences Group with its Diagnostics and Genomics business, naming Lars Holmkvist the new group’s president and senior vice president of Agilent, effective immediately. Holmkvist was previously president of the Diagnostics and Genomics Group and senior vice president of Agilent. […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
